As the 11th edition of the Paris MASH Meeting unfolds, we continue to push the boundaries of metabolic health research. This year, the spotlight turns to the integration of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in to the noncommunicable disease spectrum and its broader implications on global health.